ArticleDer Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft2018
[Analysis of spectacle lens prescriptions shows no increase of myopia in Germany from 2000 to 2015].
Article in Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 25 citations in OpenAlex.
- Temporal trends in refractive error among children and adolescents in Germany - a large-scale analysis of spectacle sales data from dispensing opticians from 2001 to 2025.Frontiers in public health · 2026Observational
- [Assessment of myopia progression].Die Ophthalmologie · 2025Review
- A Comparison of Optical Biometers Used in Children for Myopia Control.Klinische Monatsblatter fur Augenheilkunde · 2023Article
- Article
- [Post-SMILE-What myopes know about their secondary emmetropic eyes].Die Ophthalmologie · 2023Article
- [Recommendations for progressive myopia in childhood and adolescence. Statement of the DOG, BVA and the Bielschowsky Society for Strabismus Research and Neuroophthalmology : Status June 2022].Die Ophthalmologie · 2023Review
- [Optometric eye screening in schools : First results of a pilot project on logistical feasibility].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2022Article
- Prevalence and Time Trends in Myopia Among Children and Adolescents.Deutsches Arzteblatt international · 2020Article
- Reference curves for refraction in a German cohort of healthy children and adolescents.PloS one · 2020Article
- Recommendations for progressive myopia in childhood and adolescence : Statement of the German Society of Ophthalmology (DOG) and the Professional Association of German Ophthalmologists (BVA). Status December 2018.Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2020Review
- [Myopia in Germany-changes in the prevalence remain unclear].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2019Article
- [Changes in the prevalence of myopia can be derived from prescription data of spectacle lenses].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2019Article
- [Prevention of myopia].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2019Review
- [Treatment options for progressive myopia in childhood].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2019Review
- [Recommendations for progressive myopia in childhood and adolescence : Statement of the German Society of Ophthalmology (DOG) and the Professional Association of German Ophthalmologists (BVA). Status December 2018].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2019Article
- [No increase in myopia?]Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2018Article
- [Prevalence of spectacle wearers in Germany : Clear increase from 1952-2014].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2018Article
Corrections and comments
- Commented on by
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo determine whether the prevalence and magnitude of myopia among children and young adults wearing spectacles has increased in Germany from 2000 to 2015. MATERIAL AND
methodsA total of 1,223,410 refraction values from 278,432 male and 333,273 female subjects between 5 and 30 years of age were analyzed. All subjects had received a new pair of spectacles between 1 January 2000 and 31 December 2015. The parameter studied was the spherical equivalent averaged over both eyes of each subject (N = 611,705). In order to identify temporal changes, the entire period of 16 years was divided into 4 time intervals of 4 years each. In the subjects three evaluation criteria were studied as a function of age: a) the frequency of myopic subjects among all spectacle wearers, b) the mean spherical equivalent and c) the distribution of the individual spherical equivalents.
resultsa) The frequency of myopic corrections among all spectacle wearers did not increase from 2000 to 2015. At 5 years of age, 9% of all children wearing glasses were myopic (≤-0.5 D) and 80% were hyperopic (≥+0.5 D). At the age of 10, 20 and 25 years, 46%, 75% and 79%, respectively, of all spectacle wearers were myopic and 42%, 13% and 10% hyperopic. b) The mean spherical equivalent, averaged across all spectacle wearers of the same age, did not show a myopic shift from 2000 to 2015. At the age of 5, 10.3 and 27 years, the mean spherical equivalent all subjects wearing glasses was +1.74 D, 0.0 D and -1.91D. c) The refractive power distribution of the individual spherical equivalents did not change significantly from 2000 to 2015. Neither low nor high myopias were more abundant in the period 2012-2015 compared to the previous years.
conclusionThe frequency and the refractive power of myopia did not increase in Germany over the last 16 years.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.